(E)-3-Benzo[1,3]dioxol-5-ylmethyl-2-(4-methoxy-phenyl)-4-oxo-4-(3,4,5-trimethoxy-phenyl)-but-2-enoic acid

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (E)-3-Benzo[1,3]dioxol-5-ylmethyl-2-(4-methoxy-phenyl)-4-oxo-4-(3,4,5-trimethoxy-phenyl)-but-2-enoic acid
• 英文别名: (E)-3-(1,3-benzodioxol-5-ylmethyl)-2-(4-methoxyphenyl)-4-oxo-4-(3,4,5-trimethoxyphenyl)but-2-enoic acid
• 化学式: C₂₈H₂₆O₉
• 分子量: 506.509
• InChiKey: GTUFKLQCLUOULY-LKUDQCMESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  37
• 可旋转键数：
  10
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  110
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  4-benzo[1,3]dioxol-5-ylmethyl-5-hydroxy-3-(4-methoxy-phenyl)-5-(3,4,5-trimethoxy-phenyl)-5H-furan-2-one 在 盐酸 、 sodium hydroxide 作用下， 以 甲醇 、 quartz 、 水 为溶剂， 生成 (E)-3-Benzo[1,3]dioxol-5-ylmethyl-2-(4-methoxy-phenyl)-4-oxo-4-(3,4,5-trimethoxy-phenyl)-but-2-enoic acid
  参考文献：
  名称：

  US6043241

  摘要：

  公开号：

文献信息

• Ketoacid endothelin antagonists
  申请人：Warner-Lambert Company

  公开号：US06043241A1

  公开（公告）日：2000-03-28

  Compounds of the Formula I ##STR1## are nonpeptide antagonists of endothelin which are useful in treating a variety of diseasses such as elevated levels of endothelin, acute respiratory distress syndrome (ARDS), atherosclerosis, restenosis, Raynaud's phenomenon etc. The compounds are prepared by reacting an alpha-hydroxy butenolide with one or more equivalents of a suitable base, and exposing the solution to UV light.

  公式I的化合物是内皮素的非肽拮抗剂，可用于治疗多种疾病，如内皮素水平升高、急性呼吸窘迫综合症（ARDS）、动脉粥样硬化、再狭窄、雷诺现象等。这些化合物是通过将α-羟基丁烯内酯与一种或多种适当的碱反应，并将溶液暴露于紫外光下制备的。
• METHOD AND COMPOSITION FOR TREATING DIABETIC KETOACIDOSIS
  申请人：Midwestern University

  公开号：EP2424530B1

  公开（公告）日：2015-12-16
• Method and Composition for Potentiating the Antipyretic Action of a Nonopiod Analgesic
  申请人：Gulati Anil

  公开号：US20080207763A1

  公开（公告）日：2008-08-28

  A composition and method of treating fever, and optionally treating pain, is disclosed. The composition and method utilize a nonopioid analgesic and an endothelin antagonist as active agents to treat fever in mammals, including humans. The composition also is useful in the prevention and treatment of stroke and other cardiovascular disorders, like myocardial infarction.
• Method and Composition for Potentiating an Opiate Analgesic
  申请人：Gulati Anil

  公开号：US20100113396A1

  公开（公告）日：2010-05-06

  Composition and methods of treating pain and reducing or reversing tolerance to opiate analgesics are disclosed. The composition and method utilize an opiate analgesic and an endothelin antagonist as active agents to treat pain in mammals, including humans.
• Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
  申请人：Gulati Anil

  公开号：US20100173872A1

  公开（公告）日：2010-07-08

  A composition and method of treating Alzheimer's disease or a dementia of vascular origin are disclosed. The composition and method utilize an endothelin antagonist as the active agent to treat Alzheimer's disease or a dementia of vascular origin in mammals, including humans.